9-methoxyellipticine has been researched along with Leukemia L 1210 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borgna, JL; Delbarre, A; Jacquemin-Sablon, A; Le Pecq, JB; Oberlin, R; Rochefort, H; Roques, BP | 1 |
Auclair, C; Cros, S; Ding, L; Etemad-Moghadam, G; Meunier, B | 1 |
Blancy, E; Favre, G; Samadi-Baboli, M; Soula, G | 1 |
3 other study(ies) available for 9-methoxyellipticine and Leukemia L 1210
Article | Year |
---|---|
Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
Topics: Alkaloids; Animals; Breast Neoplasms; Cattle; Cell Line; DNA; Ellipticines; Female; Humans; In Vitro Techniques; Intercalating Agents; Leukemia L1210; Neoplasms, Hormone-Dependent; Receptors, Estrogen | 1985 |
Syntheses and in vitro evaluation of water-soluble "cationic metalloporphyrin-ellipticine" molecules having a high affinity for DNA.
Topics: Animals; Antineoplastic Agents; Binding, Competitive; Chemical Phenomena; Chemistry; DNA; Ellipticines; Ethidium; Intercalating Agents; Leukemia L1210; Metalloporphyrins; Mice; Pyridinium Compounds; Solubility; Water | 1991 |
Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitro.
Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Survival; Drug Carriers; Electrophoresis, Agar Gel; Ellipticines; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lipoproteins, LDL; Mice; Microscopy, Electron; Tumor Cells, Cultured | 1989 |